AI in biopharma: Where are we now?

Tuesday, October 14, 2025 | Georgia Room, NYC | Hybrid

Tomorrow is the day. As Wall Street questions the sustainability of AI investments and biopharma executives face mounting pressure to show returns, the industry's most critical conversations are happening at AI Day.

Can AI truly solve drug development’s biggest bottlenecks, or is this another hype cycle playing out in real time? Register now to join us virtually tomorrow morning.

REGISTER NOW

Virtual passes available at no charge

Join us for conversations with:

Max Jaderberg, chief AI officer, and CSO Miles Congreve from Isomorphic Labs. What’s next after their $600 million raise this past winter — and are they finally ready to enter the clinic?
Vivek Natarajan, research scientist, Google DeepMind — who co-led development on Google’s AI co-scientist project earlier this year

Max Jaderberg
Chief AI Officer Isomorphic Labs

The stakes couldn't be higher. Companies that get AI right will define the next decade of drug development. Sign up now.

REGISTER NOW